Ingersoll Rand Inc. stock has reached a 52-week high of $99.59, reflecting positive momentum with year-to-date returns of 23.45% and a 27.99% gain over the past six months. InvestingPro analysis suggests the stock is currently trading above its Fair Value, although its financial health is rated “GOOD.” Recent strategic moves include the acquisition of Scinomix, Inc. to expand its life sciences portfolio, and the appointment of Jerome Guillen, formerly of Tesla, to its Board of Directors.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Ingersoll Rand stock hits 52-week high at 99.59 USD
Ingersoll Rand Inc. stock has reached a 52-week high of $99.59, reflecting positive momentum with year-to-date returns of 23.45% and a 27.99% gain over the past six months. InvestingPro analysis suggests the stock is currently trading above its Fair Value, although its financial health is rated “GOOD.” Recent strategic moves include the acquisition of Scinomix, Inc. to expand its life sciences portfolio, and the appointment of Jerome Guillen, formerly of Tesla, to its Board of Directors.